ReferIndia News 'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

ReferIndia News

Mumbai’s Trusted Investment Experts

24+ years of financial planning, portfolio management & wealth growth.

Learn More
News Image

'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

Published on: Feb. 9, 2026, 7:31 p.m. | Source: NDTV Profit

Hims had planned to sell the drug at a sharply discounted price of $49 for the first month, which is almost $100 less than Novo's approved Wegovy pill.

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact